Kim, H., Sung, J., Bae, J. Y., Lee, P., Oh, Y. K., & Kim, H. (2022, November). Identification of osteopontin as a urinary biomarker for autosomal dominant polycystic kidney disease progression. Kidney Research and Clinical Practice.
Chicago Style (17th ed.) CitationKim, Hyunsuk, Jinmo Sung, Ju Young Bae, Poongyeon Lee, Yun Kyu Oh, and Hyunho Kim. "Identification of Osteopontin as a Urinary Biomarker for Autosomal Dominant Polycystic Kidney Disease Progression." Kidney Research and Clinical Practice Nov. 2022.
MLA (9th ed.) CitationKim, Hyunsuk, et al. "Identification of Osteopontin as a Urinary Biomarker for Autosomal Dominant Polycystic Kidney Disease Progression." Kidney Research and Clinical Practice, Nov. 2022.
Warning: These citations may not always be 100% accurate.
